Funding for this research was provided by:
Research Grants Council General Research Fund (General Research Fund 14118718)
University Grants Committee (Research Impact Fund R4012-18, General Research Fund 473408, General Research Fund 471713, General Research Fund 14118316, General Research Fund 14102719)
Croucher Foundation (Senior Medical Research Fellowship)
National Institute of Child Health and Human Development (R01-HD34243)
National Institute of Diabetes and Digestive Diseases (R01-HD34242)
Received: 24 July 2022
Accepted: 30 November 2022
First Online: 20 December 2022
: Written consents were obtained from the parents or the legal guardians. This study was approved by the Chinese University of Hong Kong Clinical Research Ethics Committee.
: R.C.W.M. has received research grants for clinical trials from AstraZeneca, Bayer, MSD, Novo Nordisk, Sanofi and Tricida Inc. and honoraria for consultancy or lectures from AstraZeneca, Bayer, Boehringer Ingelheim and Roche Diagnostics, all used to support diabetes research at the Chinese University of Hong Kong. R.C.W.M. is a co-founder of GemVCare, a technology start-up initiated with support from the Hong Kong Government Innovation and Technology Commission and its Technology Start-up Support Scheme for Universities (TSSSU). A.J.J. has received research grants for clinical trials from Abbott and Sanofi-Aventis and honoraria for consultancy for Abbott, Amgen, Medtronic and Sanofi-Aventis. No other potential conflicts of interest relevant to this article were reported.